Fidia Farmaceutici, a pharmaceutical company, completed the acqusition of the Polish affiliate of Unipharm, a privately owned pharmaceutical company. Financial terms were not disclosed. "Entering the Polish market is another important step in strengthening our position in the European market. We are pleased to invest in a country with such a great potential, a high development rate and a steadily growing economy. We are convinced that our presence in Poland will contribute to improving access to innovative treatment therapies for Polish healthcare professionals and patients and we hope to do so also by offering further therapeutic solutions soon," Carlo Pizzocaro, Fidia Farmaceutici CEO.